Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DSCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADRA1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBASH3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYL9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRAM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IQSEC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GATA3-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100129726 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GP9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NBL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCDHGC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAP1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HELZ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OBSL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GSN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EHD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DPA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRT36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEBPE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on